# Glycaemic Markers in Persons With Type 2 Diabetes on Haemodialysis

> **NCT03909269** · — · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 88 (actual)

## Conditions studied

- Diabetic Nephropathy Type 2
- Type2 Diabetes

## Interventions

- **DEVICE:** Continuous glucose monitoring
- **DIAGNOSTIC_TEST:** Glycaemic markers
- **RADIATION:** Erythrocyte life span
- **DEVICE:** Carbon monoxide (CO)-rebreathing method

## Key facts

- **NCT ID:** NCT03909269
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-01
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-04-01
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2020-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03909269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03909269, "Glycaemic Markers in Persons With Type 2 Diabetes on Haemodialysis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03909269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*